2型糖尿病心血管代谢危险因素的年龄相关模式
该研究基于四国健康调查的横断面数据,分析2型糖尿病患者心血管代谢危险因素随年龄的分布模式。结果显示,年轻患者BMI和甘油三酯更高,而收缩压和尿白蛋白/肌酐比值较低;空腹血糖和HbA1c在中年达峰。与正常糖耐量者相比,年轻糖尿病患者的空腹血糖、HbA1c、甘油三酯和舒张压差异更显著。
要点
- 年轻2型糖尿病患者BMI和甘油三酯更高,收缩压和UACR较低。
- 空腹血糖和HbA1c随年龄升高,约50-60岁达峰后下降。
- 与正常糖耐量者相比,年轻糖尿病患者的血糖和血脂差异更大。
核心结论
- 年轻2型糖尿病患者具有更高的BMI和甘油三酯,但收缩压和UACR低于老年患者。
- 空腹血糖和HbA1c在中年达峰,与正常糖耐量者的差异在年轻时更显著。
研究设计与样本
- 横断面分析,纳入澳大利亚AusDiab、美国NHANES、毛里求斯调查和印度ICMR-INDIAB四国健康调查的2型糖尿病患者。
- 样本量:AusDiab 903例,NHANES 7086例,毛里求斯调查2682例,ICMR-INDIAB 10151例。
- 采用自然样条回归分析年龄与心血管代谢危险因素的关联。
主要发现
- 在四项研究中的三项(除外ICMR-INDIAB),BMI随年龄增加而下降。
- 年轻个体低密度脂蛋白胆固醇更高(NHANES和AusDiab),高密度脂蛋白胆固醇更低(除ICMR-INDIAB外的所有研究)。
- 在AusDiab、NHANES和毛里求斯调查中,甘油三酯在年轻成人中最高,随年龄下降。
- 在AusDiab、毛里求斯调查和ICMR-INDIAB中,空腹血糖随年龄增加至45-55岁,之后下降;在NHANES中,年轻糖尿病患者空腹血糖高于老年。
- 在所有四项研究中,HbA1c随年龄增加,约50-60岁达峰后下降;新诊断糖尿病患者2小时血糖无年龄差异。
临床怎么用
- 年轻2型糖尿病患者应关注BMI和甘油三酯管理,老年患者需注意收缩压和UACR控制。
- 中年糖尿病患者应加强血糖监测,因空腹血糖和HbA1c在此阶段达峰。
局限性
- 横断面设计无法推断因果关系。
- 研究仅纳入四个国家的调查数据,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Beyond longer diabetes duration, uncertainty remains regarding the factors that contribute to a higher risk of developing complications in younger vs older people with type 2 diabetes. We investigated whether younger age was associated with a more adverse risk-factor profile compared with older age among people with type 2 diabetes. METHODS: We conducted cross-sectional analyses of demographic and clinical data from individuals with type 2 diabetes participating in national health surveys from four countries: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab), the US National Health and Nutrition Examination Survey (NHANES), the Mauritius Non-Communicable Diseases Survey (Mauritius Survey), and the Indian Council of Medical Research-India Diabetes (ICMR-INDIAB) study. Type 2 diabetes was defined according to each study's criteria, including previously diagnosed and newly diagnosed (screen-detected) diabetes (NDM). Individuals with normal glucose tolerance (NGT) were included for comparison. Regression analyses with natural splines assessed association between age at survey and cardiometabolic risk factors in each cohort. RESULTS: There were 903 participants with type 2 diabetes from AusDiab, 7086 from NHANES, 2682 from the Mauritius Survey and 10,151 from ICMR-INDIAB. In three of the four studies (excluding ICMR-INDIAB), BMI decreased with increasing age. Younger individuals had higher low-density lipoprotein cholesterol (in NHANES and AusDiab) and lower high-density lipoprotein cholesterol (in all studies except ICMR-INDIAB) compared with older individuals. In AusDiab, NHANES and the Mauritius Survey, triglycerides were highest in younger adults, declining with age. In AusDiab, the Mauritius Survey and ICMR-INDIAB, fasting plasma glucose (FPG) increased with age until 45-55 years, after which it declined. In NHANES, younger individuals with diabetes had higher FPG than older individuals. In all four studies, haemoglobin A1c (HbA1c) increased with age, peaking around 50-60 years, before declining. In NDM, 2 h plasma glucose did not vary across age. Systolic blood pressure (SBP) and urinary albumin/creatinine ratio (UACR) were higher in older individuals. Comparing diabetes with NGT, differences in FPG, HbA1c, triglycerides and diastolic blood pressure (DBP) were greater at younger than older ages in most cohorts. The same was observed for BMI and SBP, but only in two studies (AusDiab and NHANES). CONCLUSIONS/INTERPRETATION: Younger individuals with type 2 diabetes have higher BMI and triglycerides (observed in three out of four studies) but lower SBP and UACR than older individuals with type 2 diabetes. FPG and HbA1c peak in middle age. Differences relative to individuals without diabetes were more pronounced at younger than older ages for FPG, HbA1c, triglycerides and DBP, and were possibly greater for BMI and SBP. These age-related patterns likely influence the overall risk of diabetes-related complications.
引用
- Sajjadi SF, Sacre JW, Kowlessur S, et al. Age-related patterns of cardiometabolic risk factors for complications in type 2 diabetes. Diabetologia. 2026. PMID: 42171728. doi:10.1007/s00125-026-06753-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。